Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Manufactures and sells pharmaceuticals

Toyo Seikan Group Holdings, Ltd. primarily manufactures, markets, and sells metal, plastic, and glass packaging products and containers. The Company specializes in food, 18-liter, and other beverage cans. Toyo Seikan also produces steel products such as steel sheets.

Suzhou Baker Biotechnology Co., Ltd., established on 2000-03-27, Business scope includes biochemicals,fine chemistry,Electronic chemicals(non-hazardous chemicals)Development,Development and sales and related technology transfer,technical consulting,Technical Services;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Anhui Fengyuan Fermentation Technology Engineering Research Co., Ltd., established on 2003-10-27, Business scope includes biological fermentation,Chemical separation,Extraction Technology Research,to develop,application,Technology Promotion,consult,design service,Biochemical products(Free of Hazardous Chemicals,Dangerous goods,Toxic substance),Pharmaceutical Intermediates,Food and Feed Additives,Bio-based and starch-based new materials,D-lactic acid,Production of Succinic Acid,Sales,Real estate leasing,Machinery and equipment operating lease.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Sandoz AG, part of Novartis AG, is a company headquartered in Basel, Switzerland, that develops generic medicines and biosimilars.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Part of Shandong Port Group Co., Ltd., Rizhao Port Group Co., Ltd. is a Chinese company located in Rizhao that provides port handling and docking services. Zhong Tang Cai is the CEO, in this role since 2006.

Ohara Pharmaceutical Co., Ltd. manufactures, distributes, imports, and exports pharmaceuticals and related food additives. It also specializes in orphan drugs for Leukemia, Leukocytpenia, stem cell transplantation, and Parkinson's disease. The company was founded on November 5, 1964 and is headquartered in Koka, Japan.

BASF AS supplies supplementary products to pharmaceutical, as well as in the human nutrition sector. Its portfolio covers medium to high-concentrate Omega-3 fatty acids for pharmaceuticals, dietary supplements, and clinical nutrition. The company was founded on January 2, 1917 and is headquartered in Oslo, Norway.

Shandong Gangwan Construction Group Co. Ltd. is a Chinese private company, with operations in CN. The firm provides construction explosion services.

Nippon Soda Co., Ltd. engages in the chemical business. It operates through the following segments: Chemicals, Agro Products, Trading, Transportation and Warehousing, Construction, and Others. The Chemicals segment deals with the manufacture and sale of industrial chemicals, chemical products, functional materials, eco care, pharmaceuticals and intermediates, and industrial fungicides. The Agro Products segment manufactures and sells sanitizing agents, insecticides, pesticides, and industrial sanitizers. The Trading Segment covers the domestic sale, import, and export of chemicals, functional products, synthetic resin, industrial machineries, and building products. The Transportation and Warehousing segment provides transportation and warehousing services. The Construction segment handles plant construction and civil engineering works. The Others segment deals with non-ferrous metal and environmental development businesses. The company was founded by Tomonori Nakano on February 1, 1920 and is headquartered in Tokyo, Japan.

Okuno Chemical Industries Co., Ltd. is a private company headquartered in Japan, also operating in CN and HK. The firm manufactures and wholesales plating and industrial inorganic chemical products.

Bayer Schering Pharma AG is a research-centered pharmaceutical company that was formed by the merger of Schering with Bayer on 29 December 2006. The company was originally founded in 1851 by Ernst Christian Friedrich Schering. The company employs more than 26,000 people in 140 subsidiaries all over the world. The company's headquarters are in Berlin-Wedding, Germany and the forerunner company Schering's annual gross revenue was nearly € 5 billion. They retain the largest German manufacturing facility which is located in Bergkamen. The company focuses on the business areas of gynaecology and andrology, oncology, and also special therapeutics, diagnostical devices, and nuclear medicine. Schering's best-known product is their line of combined oral contraceptive pills. Through Bayer Healthcare AG, Bayer Schering Pharma is a full member of the European Federation of Pharmaceutical Industries and Associations.

Dainichiseika Color & Chemicals Mfg. Co., Ltd. engages in the manufacture and sale of inorganic and organic pigments, printing inks, coloring agents for plastics and synthetic fibers, printing agents for textile, synthetic resin and high polymer products, electronics related products, biochemical products, and spectrophotometers. Its operations are carried out through the following segments: Chemical Products, Chemicals, High Polymers, Print Integrated Systems, and Others. The Chemical Products segment provides organic and inorganic pigments, coloring agents, and information record-related materials. The Chemicals segment offers synthetic resin colorants and compounds, and various coating materials. The High Polymers segment deals with high-polymer and natural polymer products. The Print Integrated Systems segment involves printing inks and related products and services. The Others segment includes resale of raw materials, lease of real estate to group companies, and finance services. The company was founded on October 16, 1931 and is headquartered in Tokyo, Japan.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.